BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19234571)

  • 1. Electrophysiologic changes in heart failure: focus on pacemaker channels.
    Sartiani L; Stillitano F; Cerbai E; Mugelli A
    Can J Physiol Pharmacol; 2009 Feb; 87(2):84-90. PubMed ID: 19234571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast and furious: new ways to think about, study and treat cardiac arrhythmias.
    Joyner MJ; Nattel S
    J Physiol; 2009 Apr; 587(Pt 7):1383-4. PubMed ID: 19336610
    [No Abstract]   [Full Text] [Related]  

  • 3. Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart.
    Hofmann F; Fabritz L; Stieber J; Schmitt J; Kirchhof P; Ludwig A; Herrmann S
    Cardiovasc Res; 2012 Aug; 95(3):317-26. PubMed ID: 22652004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
    Doshi D; Morrow JP
    Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis.
    Michael G; Xiao L; Qi XY; Dobrev D; Nattel S
    Cardiovasc Res; 2009 Feb; 81(3):491-9. PubMed ID: 18826964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variability of the electrical properties of the pulmonary veins.
    Grant AO
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):1046-7. PubMed ID: 19572950
    [No Abstract]   [Full Text] [Related]  

  • 7. Marine omega-3 highly unsaturated fatty acids: From mechanisms to clinical implications in heart failure and arrhythmias.
    Glück T; Alter P
    Vascul Pharmacol; 2016 Jul; 82():11-9. PubMed ID: 27080538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of HCN channels slows rhythm differently in atria, ventricle and outflow tract and stabilizes conduction in the anoxic-reoxygenated embryonic heart model.
    Sarre A; Pedretti S; Gardier S; Raddatz E
    Pharmacol Res; 2010 Jan; 61(1):85-91. PubMed ID: 19818405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac electrophysiological effects of nitric oxide.
    Tamargo J; Caballero R; Gómez R; Delpón E
    Cardiovasc Res; 2010 Sep; 87(4):593-600. PubMed ID: 20587506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycaemia: reduced repolarization reserve, neurohormonal stimulation, and heart failure exacerbate susceptibility.
    Hegyi B; Ko CY; Bossuyt J; Bers DM
    Cardiovasc Res; 2021 Dec; 117(14):2781-2793. PubMed ID: 33483728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisoprolol inhibits sodium current in ventricular myocytes of rats with diastolic heart failure.
    Tang HF; Wu SL; Deng CY; Zhang WC; Kuang SJ
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):714-9. PubMed ID: 17600546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of cardiac potassium channels.
    Tamargo J; Caballero R; Gómez R; Valenzuela C; Delpón E
    Cardiovasc Res; 2004 Apr; 62(1):9-33. PubMed ID: 15023549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium channel (dys)function and cardiac arrhythmias.
    Remme CA; Bezzina CR
    Cardiovasc Ther; 2010 Oct; 28(5):287-94. PubMed ID: 20645984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of late Na+ current, a novel target to improve diastolic function and electrical abnormalities in Dahl salt-sensitive rats.
    Chi L; Belardinelli L; Zeng A; Hirakawa R; Rajamani S; Ling H; Dhalla AK
    Am J Physiol Heart Circ Physiol; 2016 May; 310(10):H1313-20. PubMed ID: 26993228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart.
    Valdivia CR; Chu WW; Pu J; Foell JD; Haworth RA; Wolff MR; Kamp TJ; Makielski JC
    J Mol Cell Cardiol; 2005 Mar; 38(3):475-83. PubMed ID: 15733907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What causes sudden death in heart failure?
    Tomaselli GF; Zipes DP
    Circ Res; 2004 Oct; 95(8):754-63. PubMed ID: 15486322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short QT syndrome. Update on a recent entity.
    Maury P; Extramiana F; Sbragia P; Giustetto C; Schimpf R; Duparc A; Wolpert C; Denjoy I; Delay M; Borggrefe M; Gaita F
    Arch Cardiovasc Dis; 2008; 101(11-12):779-86. PubMed ID: 19059573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use-dependent modulation of myocardial conduction by a new class of HERG agonists: deal breaker or cherry on top?
    Akar FG
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):930-2. PubMed ID: 20367661
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of cardiac potassium channels.
    Li GR; Dong MQ
    Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potassium channels and arrhythmia].
    Funck-Brentano C
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():9-13. PubMed ID: 1307198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.